Tag: biotech

Figure 1 Discovering new life-changing therapies has never been more urgent, yet the drug discovery process remains a complex and time-consuming endeavor. To accelerate breakthroughs, leading biotech and biopharma companies are turning to Biological Foundation Models (BioFMs), a type of advanced generative AI models trained on biological data. We are excited to announce that NVIDIA’s […]

Andrew Goldberg, Co-founder and COO of HealthVerity, joins Jared Saul, Global Head of Healthcare and Life Sciences Startups at AWS, for a discussion on industry trends shaping the way payors and pharmaceutical organizations exchange and manage data, the role of real-time data in COVD-19 vaccine development, and a vision for a flexible data strategy. HealthVerity, […]

Guest authored by Bryan Lajoie, Staff Bioinformatics Scientist at Illumina Inc. — We are pleased to announce the release of a comprehensive reanalysis of 3,202 deeply-sequenced samples from the 1000 Genomes Project(1kGP) using the Illumina DRAGEN (Dynamic Read Analysis for GENomics) Bio-IT platform. This seminal dataset will be freely available for researchers across the world to use […]

With over 75 launches and announcements of new services and major features during re:Invent, it can be hard for any technologist to keep track of the most relevant information for Healthcare and Life Science (HCLS) workloads. Explore the below recap of information important for HCLS customers and links to the top re:Invent breakout sessions. Top […]

Cryo-electron microscopy (CryoEM) of non-crystalline single particles is a biophysical technique that can be used to determine the structure of biological macromolecules and assemblies. The technique is rapidly becoming the go-to technique in the life-sciences drug discovery process for understanding protein structure. Processing data/images coming from a CryoEM microscope demands a scalable storage for large datasets (median […]

Moderna is advancing messenger RNA (mRNA) science to create a new class of mRNA medicines designed to direct the patient’s own cells to produce proteins that have a therapeutic or preventive benefit. Developing therapeutics and vaccines for a variety of diseases challenges process development and operations to establish agile and flexible manufacturing, capable of executing […]